Sun Pharma Announces Approval to Market Razadyne Tablets

Sun Pharmaceutical Industries Ltd. announced that U.S. FDA has granted tentative approval for the company’s Abbreviated New Drug Application (ANDA) for generic Razadyne galantamine tablets.
Moneycontrol.com